Načítá se...
A case control study of sarcosine as an early prostate cancer detection biomarker
BACKGROUND: Sarcosine has been investigated as a prostate cancer biomarker with mixed results concerning its predictive power. We performed a case–control evaluation of the predictive value of serum sarcosine for early detection in a population-based cohort of men undergoing prostate-specific antige...
Uloženo v:
| Vydáno v: | BMC Urol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4591628/ https://ncbi.nlm.nih.gov/pubmed/26429735 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-015-0095-5 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|